StockNews.com started coverage on shares of NuVasive ( NASDAQ:NUVA – Get Rating ) in a research note released on Sunday morning. The brokerage issued a hold rating on the medical device company's stock. Several other brokerages have also issued reports on NUVA. Truist Financial lowered shares of NuVasive from a buy rating to a hold rating and lifted their target price for the company from $51.00 to $52.50 in a research report on Friday, February 10th. TheStreet upgraded shares of NuVasive from a d+ rating to a c- rating in a research report on Tuesday, April 11th.

https://www.dailypolitical.com/2023/05/22/nuvasive-nasdaqnuva-coverage-initiated-by-analysts-at-stocknews-com.html

#dailypolitical